OR4C6 Antibody

What is OR4C6 and what is its cellular localization?

OR4C6 (Olfactory Receptor Family 4 Subfamily C Member 6) functions as an odorant receptor protein in the olfactory system. It is primarily localized in the cell membrane as a multi-pass membrane protein, traversing the lipid bilayer multiple times . This protein has alternative names including Olfactory Receptor OR11-138, which may appear in some literature . The gene has been assigned the ID 219432 and can be referenced through the UniProt database as OR4C6_HUMAN . Understanding the cellular localization is crucial for experimental design, particularly for immunofluorescence studies that require appropriate cell permeabilization techniques to access the membrane-bound epitopes.

What applications can OR4C6 antibodies be used for in research?

OR4C6 antibodies have been validated for multiple research applications including Western Blot (WB), Immunofluorescence (IF), and Enzyme-Linked Immunosorbent Assay (ELISA) . Each application requires specific methodological considerations and optimization. For example, the recommended dilution ranges vary significantly depending on the technique:

These applications enable researchers to detect endogenous levels of OR4C6 protein in various experimental systems, providing tools for studying olfactory receptor expression patterns and protein-protein interactions .

Which species does the OR4C6 antibody recognize?

Commercial OR4C6 antibodies have demonstrated reactivity across multiple species including human, rat, and mouse . This cross-species reactivity is particularly valuable for comparative studies examining evolutionary conservation of olfactory receptor functions. Researchers should note that while sequence similarity suggests cross-reactivity, validation experiments should still be performed when using the antibody in a new species context to confirm specificity . The antibody's ability to recognize epitopes across species boundaries suggests conservation of the 193-242 amino acid region that serves as the immunogen .

What are the optimal storage conditions for OR4C6 antibodies?

OR4C6 antibodies should be stored at -20°C for up to one year from the date of receipt to maintain optimal activity . Researchers should strictly avoid repeated freeze-thaw cycles as these can progressively degrade antibody quality and reduce binding efficiency . Most commercial preparations are formulated in PBS containing 50% Glycerol, 0.5% BSA, and 0.02% Sodium Azide, which helps stabilize the antibody during storage . Working aliquots should be prepared upon first thaw to minimize repeated exposure to room temperature and freeze-thaw stress.

What considerations are important for validating OR4C6 antibody specificity?

Validating antibody specificity is critical for meaningful OR4C6 research. Researchers should implement multiple validation approaches including positive and negative controls, epitope blocking experiments, and knockout/knockdown verification when possible. Recent advances in antibody specificity research demonstrate that computational models can be employed to predict cross-reactivity and binding profiles . When validating OR4C6 antibodies, researchers should consider that:

• The antibody has been affinity-purified using epitope-specific immunogen derived from the 193-242 amino acid region of human OR4C6 .

• Different binding modes associated with specific ligands may influence antibody recognition .

• Closely related olfactory receptors (such as OR4C5, OR4C3) may share sequence homology with the immunogen region .

A thorough validation protocol should include Western blot analysis comparing bands with expected molecular weight, positive tissue controls known to express OR4C6, and if possible, comparison with alternative antibody clones targeting different epitopes.

How can computational approaches improve OR4C6 antibody design and selection?

Recent advancements in computational biology have revolutionized antibody design, including for olfactory receptors like OR4C6. Biophysics-informed models can now identify and disentangle multiple binding modes associated with specific ligands, enabling the design of antibodies with customized specificity profiles . Researchers working with OR4C6 can leverage these computational approaches to:

• Predict cross-reactivity with other olfactory receptor family members.

• Design antibodies with either highly specific binding to OR4C6 or controlled cross-reactivity with related receptors.

• Mitigate experimental artifacts and biases in selection experiments.

The combination of high-throughput sequencing data and computational analysis allows researchers to overcome limitations of traditional selection methods, which are constrained by library size and control over specificity profiles . For OR4C6 specifically, these approaches could help design antibodies that can distinguish between the highly similar olfactory receptor family members.

What are optimal protocols for using OR4C6 antibodies in Western Blot applications?

For Western Blot applications using OR4C6 antibodies, researchers should follow this optimized protocol:

• Sample Preparation: Extract proteins using a membrane protein-compatible lysis buffer containing 1% Triton X-100 or similar detergent to effectively solubilize the membrane-bound OR4C6.

• Electrophoresis Conditions: Use 10-12% SDS-PAGE gels for optimal separation of OR4C6 protein.

• Transfer Parameters: Employ wet transfer at 30V overnight at 4°C to ensure efficient transfer of hydrophobic membrane proteins.

• Blocking: Block with 5% non-fat dry milk in TBST for 1 hour at room temperature.

• Primary Antibody Incubation: Dilute the OR4C6 antibody between 1:500-1:2000 in blocking buffer and incubate overnight at 4°C .

• Detection: Use HRP-conjugated secondary antibodies and enhanced chemiluminescence for visualization.

Researchers should note that membrane proteins like OR4C6 may require optimization of denaturation conditions, as excessive heating can cause aggregation. A 37°C incubation for 30 minutes in sample buffer may yield better results than the traditional 95°C for 5 minutes approach.

What methodological considerations are important for immunofluorescence studies with OR4C6 antibodies?

When conducting immunofluorescence studies with OR4C6 antibodies, researchers should consider:

• Fixation Method: For membrane proteins like OR4C6, 4% paraformaldehyde fixation for 10-15 minutes at room temperature is recommended to preserve membrane structure.

• Permeabilization: Gentle permeabilization with 0.1% Triton X-100 for 5-10 minutes is typically sufficient for accessing epitopes.

• Blocking: Use 5% normal serum from the same species as the secondary antibody for 1 hour at room temperature.

• Antibody Dilution: For OR4C6 antibodies, the recommended dilution range is 1:200-1:1000 .

• Incubation Conditions: Incubate with primary antibody overnight at 4°C in a humidified chamber.

• Controls: Include a secondary-only control and, if possible, a tissue known to be negative for OR4C6 expression.

Co-localization studies with established membrane markers can provide additional validation of correct subcellular localization. Confocal microscopy is particularly valuable for confirming membrane localization of OR4C6.

How can researchers troubleshoot inconsistent results with OR4C6 antibodies?

When encountering inconsistent results with OR4C6 antibodies, systematic troubleshooting approaches should be implemented:

• Antibody Quality: Verify antibody integrity by checking for precipitates and adhere to proper storage conditions at -20°C, avoiding freeze-thaw cycles .

• Epitope Accessibility: For this membrane protein, ensure adequate permeabilization while preserving epitope structure.

• Protocol Optimization: Adjust antibody concentration (1:200-1:1000 for IF; 1:500-1:2000 for WB) based on signal-to-noise ratio .

• Sample Preparation: Verify protein denaturation conditions, especially for membrane proteins which may require specialized extraction methods.

• Cross-Reactivity: Consider potential cross-reactivity with similar olfactory receptors by performing epitope-blocking experiments.

If problems persist, researchers can leverage computational approaches for predicting antibody specificity and binding characteristics to identify potential sources of inconsistency . Additionally, comparing results with alternative antibody clones targeting different epitopes of OR4C6 may help identify epitope-specific issues.

How should researchers design experiments to study OR4C6 expression patterns?

Designing robust experiments to study OR4C6 expression requires a multi-technique approach:

• Tissue Selection: Include known positive controls such as olfactory epithelium tissues alongside experimental samples.

• Technique Triangulation: Combine protein detection (Western blot, IF) with mRNA analysis (qRT-PCR, in situ hybridization) for comprehensive validation.

• Quantification Methods: For Western blot, normalize OR4C6 signals to housekeeping proteins; for IF, use standardized exposure settings and quantitative image analysis.

• Antibody Selection: The polyclonal antibody targeting amino acids 193-242 provides good coverage for detection .

• Controls: Include blocking peptide controls to confirm specificity of antibody binding.

When conducting comparative studies across species, researchers should note that the antibody demonstrates reactivity with human, rat, and mouse OR4C6 , but expression patterns may vary significantly between species and tissues.

What are the considerations for analyzing OR4C6 in complex tissue samples?

Analyzing OR4C6 in complex tissue samples presents several methodological challenges:

• Background Reduction: For IF applications, use autofluorescence reduction techniques such as Sudan Black B treatment (0.1% solution for 10 minutes).

• Signal Amplification: Consider tyramide signal amplification for low-abundance detection.

• Co-localization Analysis: Pair OR4C6 antibody with cell-type specific markers to identify expressing cell populations.

• Tissue Processing: Optimize antigen retrieval methods (citrate buffer, pH 6.0, 95°C for 20 minutes) for fixed tissues.

• Single-cell Approaches: For heterogeneous tissues, consider combining antibody detection with single-cell isolation techniques.

When analyzing Western blot data, researchers should be aware that glycosylation states may affect the apparent molecular weight of OR4C6. Additionally, detergent selection during extraction is critical for complete solubilization of this membrane protein.

How can researchers accurately compare OR4C6 expression across different experimental conditions?

To accurately compare OR4C6 expression across different experimental conditions:

• Standardized Protocols: Maintain consistent sample processing, antibody concentrations, and detection parameters across all experimental groups.

• Internal Controls: Include calibration samples on each blot or slide for inter-experimental normalization.

• Quantitative Analysis: For Western blots, use densitometry with dynamic range validation; for IF, employ standardized image acquisition settings and quantitative analysis software.

• Statistical Approaches: Use appropriate statistical tests based on data distribution, with multiple biological and technical replicates.

• Normalization Strategy: For membrane proteins like OR4C6, normalize to membrane-specific housekeeping proteins rather than cytosolic markers.

When comparing across species, researchers should consider potential differences in epitope accessibility or post-translational modifications that may affect antibody recognition despite the documented cross-species reactivity .

What emerging technologies might enhance OR4C6 antibody research?

Several emerging technologies show promise for advancing OR4C6 antibody research:

• Computational Antibody Design: Biophysics-informed models can predict and design antibodies with customized specificity profiles for OR4C6 and related olfactory receptors .

• Single-cell Proteomics: New approaches combining antibody detection with single-cell resolution could reveal cell-type specific expression patterns.

• Proximity Labeling: BioID or APEX2-based approaches combined with OR4C6 antibodies could identify interaction partners.

• Super-resolution Microscopy: Techniques like STORM or PALM could provide nanoscale insights into OR4C6 membrane organization.

• Cryo-EM: Structural studies using OR4C6 antibodies as fiducial markers could enhance understanding of receptor organization.

The integration of computational approaches with experimental validation represents a particularly promising direction, as highlighted by recent advances in antibody specificity prediction and design .

What are the current limitations in OR4C6 antibody research and how might they be addressed?

Current limitations in OR4C6 antibody research include:

• Epitope Coverage: Commercial antibodies target a specific region (193-242) , potentially missing conformational epitopes. Development of antibodies targeting multiple epitopes could provide more comprehensive analysis.

• Specificity Challenges: The high sequence similarity between olfactory receptor family members creates potential cross-reactivity issues. Advanced computational approaches for antibody specificity prediction could address this limitation .

• Functional Correlation: Current antibodies are primarily for detection rather than functional modulation. Development of function-blocking antibodies could enhance mechanistic studies.

• Standardization: Variation between antibody lots creates reproducibility challenges. Implementation of more rigorous validation standards and reference materials would improve consistency.

• Membrane Protein Challenges: The multi-pass membrane nature of OR4C6 creates technical difficulties in antibody access. Optimized permeabilization and epitope retrieval methods could improve detection sensitivity.

Addressing these limitations will require collaborative efforts between computational biologists, protein engineers, and experimental researchers to develop next-generation antibody tools for OR4C6 research.